Obsidian Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Cambridge, MA
OBX chart
What traders are saying about $OBX
Latest postsObsidian Therapeutics, Inc. news
- Engineered TIL Therapy Shows Early Activity in Checkpoint Inhibitor–Resistant Melanoma
Pharmacy Times ·
- Dole Posts Downbeat Q3 Results, Joins NVIDIA And Other Big Stocks Moving Lower In Monday’s Pre-Market Session
Benzinga ·
- Emerald Bioventures Backs Obsidian Deal at Galera Therapeutics with 26.5% Stake
TradingView ·
- Obsidian Therapeutics - Topline Data From Pha
Moomoo ·
- Why Is Obsidian Therapeutics (NASDAQ:OBX) Up 30.21% From a USD 9.60 Prior Close?
kalkine.ca ·
- Obsidian Therapeutics Amsoki-Cel Nsclc Phase 1 Data Expected First Half 2027
TradingView ·
- Obsidian Therapeutics to Present Updated Amsoki-cel Efficacy and Pooled Safety Data in Advanced Melanoma at SITC 2026 Annual Meeting
Yahoo Finance ·
- OBX News Today | Why did Obsidian Therapeutics stock go down today? $OBX
MarketBeat ·
- Obsidian Therapeutics to Present Updated Amsoki-cel (OBX-115) Phase 1/2 Data in Advanced Melanoma at SITC 2026 Annual Meeting
Yahoo Finance ·
- Obsidian Therapeutics (OBX) Stock Dropped, So What Is Behind The Attention Now?
Yahoo Finance ·
- Zillow downgraded, Global Payments upgraded: Wall Street's top analyst calls
Yahoo Finance ·
- Best Buy downgraded, Bristol Myers upgraded: Wall Street's top analyst calls
Yahoo Finance ·
Obsidian Therapeutics, Inc. key financials
| USD | 2025 | 2024 |
|---|---|---|
| Revenue | $0 | $0 |
| Net income | -$100.6M | -$83.1M |
| Diluted EPS | $-7.22 | $-6.47 |
| Total assets (year end) | $88.6M | $183.7M |
| Cash and equivalents (year end) | $40.4M | $49.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Obsidian Therapeutics, Inc.
- Ticker
- OBX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Cambridge, MA
- Fiscal year end
- December 31
- SEC CIK
- 2130606
- Former names
- Gazelle Parent, Inc.
Frequently asked questions
What exchange is Obsidian Therapeutics, Inc. listed on?
Obsidian Therapeutics, Inc. trades on the Nasdaq under the ticker symbol OBX.
What industry is Obsidian Therapeutics, Inc. in?
Obsidian Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Obsidian Therapeutics, Inc. headquartered?
Obsidian Therapeutics, Inc.'s business address on file with the SEC is in Cambridge, MA.
When does Obsidian Therapeutics, Inc.'s fiscal year end?
Obsidian Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Obsidian Therapeutics, Inc. report?
Obsidian Therapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.